Act locally. Think globally.

AlbyPharma Ireland, is a well-established pharmaceutical company with 40 plus years of experience supplying European and US markets.

First oral FDA-Approved Beta-Lactam facility in Europe.

Has solid dosage forms, liquid-line, sachets & dry powder suspension manufacturing capabilities.

Full in-house R&D capabilities.

Fully equipped Analytical & Development labs.

Scroll down

Europe’s only independent FDA Approved Beta-Lactam plant.

Both plants (Unit I & Unit II) are self contained facilities, capable of supporting the entire production process completely. Stability and validation testing are conducted on site.
The process technology includes but not limited to: Pelletizing and Coating, Sustained Release Tablets and Hard Gelatin/Soft Gelatin Capsules.

Quality is our pride & commitment

Working with AlbyPharma will give you access to a very high standard of analytical services and capabilities. As a partner you have a purpose and AlbyPharma team will make sure that the means will follow.


Our SAP system is fully operating and backed-up in cloud, which means that all data will be fully secured at all time and this gives our customers a trust in our process.

It is effectively provides real-time business applications and link to number of other systems to track shipments and delivery as ongoing live stream.

Go to top

Quality is our pride & commitment

Go to article: Home | Where is my mind?Go to article: In this issueGo to article: Scandinavian Health Company InsightGo to article: Scandinavian HealthGo to article: ContentsGo to article: NSFGo to article: NewsGo to article: Daiichi JitsugyoGo to article: The pharma industry briefingGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Thumbs up for esketamine sheds light on potential for ketamineGo to article: Phoenix group Company InsightGo to article: Phoenix group Go to article: Charting the life and times of the EMA as it leaves LondonGo to article: Swiss WorldCargoGo to article: Capsugel Company InsightGo to article: CapsugelGo to article: Medical cannabis in the UK: how has the roll out gone so far? Go to article: EmboCapsGo to article: Barc Lab Go to article: Drug development: the researchers driving an open-science approachGo to article: Freudenberg MedicalGo to article: AlbypharmaGo to article: The drugs fighting memory lossGo to article: Senn ChemicalsGo to article: Pharma HempGo to article: RUNLABS: empowering life science through flexible working environmentsGo to article: Spirax SarcoGo to article: Spirax Sarco Company InsightGo to article: EventsGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: B&W TekGo to article: Next issueGo to article: PfanstiehlGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Hapa Company InsightGo to article: Contract Pharmaceuticals Limited Canada